CGT Asia Guangzhou 2024
9.26 - 9.27
Guangzhou, China
Welcome to our booth B9.
Please click the image below to get more information.
The summit will discuss the latest research progress, technology application and market trends in the field of CGT, and jointly promote the rapid development of the cell and gene therapy industry.
As the leader of the industry, CGT Asia series of summits integrates domestic and international and industry-wide high-quality resources to grasp the direction of the industry from a professional perspective and with an eye on development, and to set off a "storm of ideas". This year's summit will have 60+ domestic and foreign industry experts to share their experience and application cases, interpret the latest trends and ideas in the industry, in-depth insight into the development of the industry and the industry's new trends, the content focuses on CGTBD overseas and investment and financing of the CGT industry's global business development, neurodegenerative diseases, stem cell therapy, gene therapy, RNA therapy, rare diseases, DC cell therapy, mini-nucleic acid, modular CAR- T immunocell therapy TCR-T immunotherapies, and the development of the industry's newest technologies. T immune cell therapy TCR-T, CAR-NK, CRISPR/CAS9 gene editing, iPSC, filing scheme, interpretation of relevant policies and regulations, large-scale production process, Industry 4.0, artificial intelligence, AAV, new wind direction of investment in CGT industry, cell product testing, etc. CGT Asia Guangzhou 2024 (Guangzhou Station) will bring you an All-round and brand-new technology feast of cell therapy and gene therapy research and industry.